Farisano G, Trivello R, Moschen M E, Bonello C, Baldo V, Moretti G, Majori S, Marin F, Piron L, Renzulli G
Institute of Hygiene, University of Padua.
Ann Clin Lab Sci. 1995 Mar-Apr;25(2):200-6.
In 1976, a cohort survey on the persistence of neutralizing antibodies in children regularly immunized 1 to 4 years earlier with the Sabin attenuated vaccine (OPV) was undertaken in the Venice mainland. Subsequent serological evaluations in the same cohort were carried out in 1983 and 1993. A macroneutralization test using a 1:4 initial serum dilution was utilized in the 1976 and 1983 survey years. In the 1993 survey a microneutralization test using a 1:2 initial dilution was utilized. In this survey, however, sera were tested using both the latter microneutralization test and the former test. Using the former method, the results indicate that the OPV-induced humoral immunity to poliovirus 1 and 2 remain fairly stable after the initial decrease, whereas antibodies to poliovirus 3 are further declining. Using the latter more sensitive method the seropositivity rates were found to be equal or close to 100 percent. The results of our follow-up survey thus indicate that the OPV-induced humoral immunity is long-lasting when tested with a highly sensitive and reproducible method. The clinical protection that ensues after OPV-immunization is probably lifelong similar to that which follows the natural infection.
1976年,在威尼斯大陆对1至4年前定期接种萨宾减毒活疫苗(口服脊髓灰质炎疫苗,OPV)的儿童体内中和抗体的持久性进行了一项队列研究。1983年和1993年对同一队列进行了后续血清学评估。在1976年和1983年的调查年份中,采用了初始血清稀释度为1:4的宏观中和试验。在1993年的调查中,采用了初始稀释度为1:2的微观中和试验。然而,在本次调查中,血清同时采用了后一种微观中和试验和前一种试验进行检测。采用前一种方法,结果表明,口服脊髓灰质炎疫苗诱导的针对脊髓灰质炎病毒1型和2型的体液免疫在最初下降后仍保持相当稳定,而针对脊髓灰质炎病毒3型的抗体则进一步下降。采用后一种更敏感的方法,血清阳性率被发现等于或接近100%。因此,我们的随访研究结果表明,当用高度敏感且可重复的方法检测时,口服脊髓灰质炎疫苗诱导的体液免疫是持久的。口服脊髓灰质炎疫苗免疫后产生的临床保护作用可能与自然感染后的保护作用一样是终身的。